HealthTree Logo
search more_vert
person Sign In / Create Account
The new GSK Antibody Drug Conjugate in Multiple Myeloma with Dr. Maria Chaudhry, OSU James Cancer Center
The new GSK Antibody Drug Conjugate in Multiple Myeloma with Dr. Maria Chaudhry, OSU James Cancer Center image
HealthTree Podcast for Multiple Myeloma
event Sep 13, 2018 / 11:00AM MDT

Event Description

Maria Chaudhry, MD
The Ohio State University, The James Cancer Center 
Interview Date: September 13, 2018

A new drug by GlaxoSmithKlein drew attention at last year's American Society of Hematology (ASH) meeting for multiple myeloma patients. Learn more about this antibody drug conjugate which carries a toxic load directly to myeloma cells using the BCMA target. Dr. Chaudhry shares the outcomes of the first Phase I clinical trial and the opening of the Phase II study. The GSK drug targets the common BCMA protein found on the surface of myeloma cells and in the Phase I study, the drug was used alone with strong results, even for patients who had relapsed after common myeloma therapies like Velcade, Revlimid and daratumumab (Darzalex). A Phase II study is now underway. Learn more about how the drug works and what is involved in participating. 

Thanks to our episode sponsor, Celgene Corporation.

Schedule & Agenda

Dr. Maria Chaudhry & Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Leukemia Newsletter" for Leukemia news, life with Leukemia stories, Leukemia clinical trials, Leukemia 101 articles and events with Leukemia experts.